A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer

Published:2019-03 Issue: Volume:12 Page:56-67
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Chawla Sant P.,Bruckner Howard,Morse Michael A.,Assudani Nupur,Hall Frederick L.,Gordon Erlinda M.

Funder

National Science Foundation

NIH

NATO Scientific Exchange Program

American Heart Association

Whittier Family Foundation

FDA Office of Orphan Products Division

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference42 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

2. American Cancer Society (2018). Cancer facts & figures 2018. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf.

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011

4. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N. Engl. J. Med.,2013

5. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial;Wang-Gillam;Lancet,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart Nanobiomaterials for Gene Delivery in Localized Cancer Therapy: An Overview from Emerging Materials and Devices to Clinical Applications;Current Cancer Drug Targets;2024-04-19

2. Challenges and Opportunities of Gene Therapy in Cancer;OBM Genetics;2024-03-04

3. Overcoming drug resistance with specific nano scales to targeted therapy: Focused on metastatic cancers;Pathology - Research and Practice;2024-03

4. Role of gene therapy in treatment of cancer with craniofacial regeneration—current molecular strategies, future perspectives, and challenges: a narrative review;Journal of Yeungnam Medical Science;2024-01-31

5. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy;Molecular Biology Reports;2024-01-28